Shortage of human intravenous immunoglobulin—reasons and possible solutions

[1]  L. Cavacini,et al.  Treatment of pemphigus vulgaris with rituximab and intravenous immune globulin. , 2006, The New England journal of medicine.

[2]  J. Ravetch,et al.  Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation , 2006, Science.

[3]  O. Abdel-Wahab,et al.  Current usage of intravenous immune globulin and the rationale behind it: the Massachusetts General Hospital data and a review of the literature , 2006, Transfusion.

[4]  A. Buchacher,et al.  Purification of intravenous immunoglobulin G from human plasma – aspects of yield and virus safety , 2006, Biotechnology journal.

[5]  J. Callum,et al.  Changes in intravenous immunoglobulin prescribing patterns during a period of severe product shortages, 1995–2000 , 2005, Vox sanguinis.

[6]  J. Freedman,et al.  Can antibodies with specificity for soluble antigens mimic the therapeutic effects of intravenous IgG in the treatment of autoimmune disease? , 2005, The Journal of clinical investigation.

[7]  C. Schreiner,et al.  Properties of a new intravenous immunoglobulin (IGIV‐C, 10%) produced by virus inactivation with caprylate and column chromatography , 2003, Vox sanguinis.

[8]  S. Kaveri,et al.  Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. , 2001, The New England journal of medicine.

[9]  S. Kaveri,et al.  Normal human immunoglobulin suppresses experimental myasthenia gravis in SCID mice , 1999, European journal of immunology.

[10]  W. Fridman,et al.  Infusion of Fcγ fragments for treatment of children with acute immune thrombocytopenic purpura , 1993, The Lancet.

[11]  W. Fridman,et al.  Infusion of Fc gamma fragments for treatment of children with acute immune thrombocytopenic purpura. , 1993, Lancet.